DBI Investor News: If You Have Suffered Losses in Designer Brands Inc. (NYSE: DBI), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire July 28, 2025 NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on […]
Sarepta Therapeutics (SRPT) Tanks 36% After 3rd Patient Death, SRPT Securities Class Action Pending; Investors With Substantial Losses And Persons With Knowledge Encouraged To Contact Hagens Berman GlobeNewswire July 28, 2025 SAN FRANCISCO, July 28, 2025 (GLOBE NEWSWIRE) — On July 18, 2025, investors saw the price of their shares in Sarepta Therapeutics, Inc. (NASDAQ:
(NASDAQ:MRVI), SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) — Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2025 financial and operating results after the market close on Monday, August 11, 2025, and will host a conference call
Maravai LifeSciences To Host Earnings Conference Call on Monday, August 11, 2025 GlobeNewswire July 28, 2025 SAN DIEGO, July 28, 2025 (GLOBE NEWSWIRE) — Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans to announce its second quarter 2025 financial and operating results
(NYSE:HIMS), PHILADELPHIA, July 28, 2025 (GLOBE NEWSWIRE) — Berger Montague, a national securities litigation law firm, is investigating potential securities fraud claims against Hims & Hers Health Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS). The firm is examining whether Hims & Hers, during the Class Period from April 29, 2025 through June 22,
HIMS & HERS HEALTH (NYSE: HIMS) CLASS ACTION NOTICE: Berger Montague Encourages Investors With Substantial Losses to Contact the Firm By August 25, 2025 GlobeNewswire July 28, 2025 PHILADELPHIA, July 28, 2025 (GLOBE NEWSWIRE) — Berger Montague, a national securities litigation law firm, is investigating potential securities fraud claims against Hims & Hers Health Inc.
(NYSE:HIMS), Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, July 28, 2025 (GLOBE NEWSWIRE) — The Portnoy Law Firm advises Hims & Hers Health, Inc. (“Hims & Hers Health” or the “Company”) (NYSE: HIMS) investors of a class action representing investors that bought securities between
Hims & Hers Health, Inc.: Please contact the Portnoy Law Firm to recover your losses. August 25, 2025 Deadline to file Lead Plaintiff Motion GlobeNewswire July 28, 2025 Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, July 28, 2025 (GLOBE NEWSWIRE) — The Portnoy Law
Jones Walker LLP is pleased to welcome Chris Hannanas a partner in the Maritime Practice Group and a member of the maritime litigation, arbitration, and dispute resolution team in the New Orleans office. https://mma.prnewswire.com/media/2739589/Jones_Walker_welcomes_Chris_Hannan_as_a_partner.jpg “We are pleased to welcome Chris to our maritime practice group,” said the firm's managing partner Bill Hines. “He has extensive
NEW YORK, NY / ACCESS Newswire / July 28, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Replimune Group, Inc. ("Replimune Group, Inc.") (NASDAQ:REPL) concerning possible violations of federal securities laws. On July 22, 2025, Replimune announced that it received a Complete Response Letter from the FDA rejecting its